Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2438]

Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma

Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma

FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after research shows improved outcomes for patients

FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after research shows improved...

New urine test has higher diagnostic accuracy for prostate cancer

New urine test has higher diagnostic accuracy for prostate cancer

Adding chemotherapy to hormone therapy helps control locally advanced prostate cancer

Adding chemotherapy to hormone therapy helps control locally advanced prostate cancer

New SPECT/CT technique shows impressive biomarker identification, offers increased access for prostate cancer patients

New SPECT/CT technique shows impressive biomarker identification, offers increased access for prostate cancer...

Next-generation treatments hitch a ride into cancer cells

Next-generation treatments hitch a ride into cancer cells

Treatment for first clinical trial patient with gamma delta CAR T for bone metastatic prostate cancer

Treatment for first clinical trial patient with gamma delta CAR T for bone metastatic prostate cancer

New insight into combatting drug-resistant prostate cancer

New insight into combatting drug-resistant prostate cancer

A new screening protocol can detect aggressive prostate cancers more selectively

A new screening protocol can detect aggressive prostate cancers more selectively

AACR 2024: Proteogenomic signatures may help identify risk of prostate cancer progression in patients with African and European ancestries

AACR 2024: Proteogenomic signatures may help identify risk of prostate cancer progression in patients with African...

More from ecancer